Cargando…

Acute Ketamine Infusion in Rat Does Not Affect In Vivo [(11)C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5

Detecting changes in metabotropic glutamate receptor 5 (mGluR5) availability through molecular imaging with the positron emission tomography (PET) tracer [(11)C]ABP688 is valuable for studying dysfunctional glutamate transmission associated with neuropsychiatric disorders. Using an infusion protocol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosten, Lauren, Verhaeghe, Jeroen, wyffels, Leonie, Stroobants, Sigrid, Staelens, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144515/ https://www.ncbi.nlm.nih.gov/pubmed/30213221 http://dx.doi.org/10.1177/1536012118788636

Ejemplares similares

Noninvasive Relative Quantification of [(11)C]ABP688 PET Imaging in Mice Versus an Input Function Measured Over an Arteriovenous Shunt
por: Verhaeghe, Jeroen, et al.
Publicado: (2018)

Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington’s Disease: a Longitudinal PET Study
por: Bertoglio, Daniele, et al.
Publicado: (2020)

Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone
por: R Zimmer, Eduardo, et al.
Publicado: (2015)

MicroPET Outperforms Beta-Microprobes in Determining Neuroreceptor Availability under Pharmacological Restriction for Cold Mass Occupancy
por: Glorie, Dorien, et al.
Publicado: (2017)

Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D(1)R Radioligand [(11)C]SCH23390 in Healthy and Diseased Mice
por: Bertoglio, Daniele, et al.
Publicado: (2020)

Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [(11)C]ABP688 Positron-Emission Tomography (PET) Imaging
por: DuBois, Jonathan M., et al.
Publicado: (2016)

Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer’s dementia
por: Treyer, Valerie, et al.
Publicado: (2020)

Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
por: Elvas, Filipe, et al.
Publicado: (2015)

Longitudinal Characterization of [(18)F]-FDG and [(18)F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model
por: Waldron, Ann-Marie, et al.
Publicado: (2016)

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [(11)C]ABP688 and PET imaging study in depression
por: Esterlis, Irina, et al.
Publicado: (2017)

In vitro and In vivo Assessment of Suitable Reference Region and Kinetic Modelling for the mGluR1 Radioligand [(11)C]ITDM in Mice
por: Bertoglio, Daniele, et al.
Publicado: (2019)

Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
por: Bertoglio, Daniele, et al.
Publicado: (2021)

Validation and noninvasive kinetic modeling of [(11)C]UCB-J PET imaging in mice
por: Bertoglio, Daniele, et al.
Publicado: (2019)

Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [(11)C]UCB-J PET study in a model of obsessive–compulsive disorder-like behaviour
por: Glorie, Dorien, et al.
Publicado: (2020)

Impact of framing scheme optimization and smoking status on binding potential analysis in dynamic PET with [(11)C]ABP688
por: Régio Brambilla, Cláudia, et al.
Publicado: (2023)

Translation of Preclinical PET Imaging Findings: Challenges and Motion Correction to Overcome the Confounding Effect of Anesthetics
por: Miranda, Alan, et al.
Publicado: (2021)

Spatiotemporal Kernel Reconstruction for Linear Parametric Neurotransmitter PET Kinetic Modeling in Motion Correction Brain PET of Awake Rats
por: Miranda, Alan, et al.
Publicado: (2022)

MR-based spatial normalization improves [(18)F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington’s disease
por: Bertoglio, Daniele, et al.
Publicado: (2018)

Sex differences in [(11)C]ABP688 binding: a positron emission tomography study of mGlu5 receptors
por: Smart, Kelly, et al.
Publicado: (2019)

Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
por: Bertoglio, Daniele, et al.
Publicado: (2022)

A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
por: Ottoy, Julie, et al.
Publicado: (2017)

In Vivo Imaging of mGluR5 Changes during Epileptogenesis Using [(11)C]ABP688 PET in Pilocarpine-Induced Epilepsy Rat Model
por: Choi, Hongyoon, et al.
Publicado: (2014)

Estimation of and correction for finite motion sampling errors in small animal PET rigid motion correction
por: Miranda, A., et al.
Publicado: (2018)

Metabotropic Glutamate Receptor Subtype 5 in Alcohol-Induced Negative Affect
por: Kasten, Chelsea R., et al.
Publicado: (2019)

Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract
por: Ferrigno, Andrea, et al.
Publicado: (2017)

mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [(11)C]ABP688 PET/MR-EEG
por: Régio Brambilla, Cláudia, et al.
Publicado: (2022)

Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [(18)F]PSS232 in the Rat Brain
por: Müller Herde, Adrienne, et al.
Publicado: (2018)

Awake (18)F-FDG PET Imaging of Memantine-Induced Brain Activation and Test–Retest in Freely Running Mice
por: Miranda, Alan, et al.
Publicado: (2019)

Metabotropic glutamate receptor subtype 2 is a cellular receptor for rabies virus
por: Wang, Jinliang, et al.
Publicado: (2018)

Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [(11)C]ABP688
por: DeLorenzo, C, et al.
Publicado: (2015)

Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013)

Kinetic fingerprinting of metabotropic glutamate receptors
por: Kukaj, Taulant, et al.
Publicado: (2023)

Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats
por: Xu, Jian, et al.
Publicado: (2009)

Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening
por: Mueller, Ralf, et al.
Publicado: (2010)

Nerve Demyelination Increases Metabotropic Glutamate Receptor Subtype 5 Expression in Peripheral Painful Mononeuropathy
por: Ko, Miau-Hwa, et al.
Publicado: (2015)

Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window
por: Mihov, Yoan, et al.
Publicado: (2016)

Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
por: Brašić, James R., et al.
Publicado: (2020)

Therapeutic promise and principles: Metabotropic glutamate receptors
por: Maiese, Kenneth, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_t7j93gble6jkvni1oghgchd7gp